KLA (KLAC)
(Delayed Data from NSDQ)
$696.17 USD
-59.97 (-7.93%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $697.45 +1.28 (0.18%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth A Momentum B VGM
KLA (KLAC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$870.91 | $990.00 | $680.00 | 15.18% |
Price Target
Based on short-term price targets offered by 22 analysts, the average price target for KLA comes to $870.91. The forecasts range from a low of $680.00 to a high of $990.00. The average price target represents an increase of 15.18% from the last closing price of $756.14.
Analyst Price Targets (22)
Broker Rating
KLA currently has an average brokerage recommendation (ABR) of 1.84 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 25 brokerage firms. The current ABR compares to an ABR of 1.88 a month ago based on 24 recommendations.
Of the 25 recommendations deriving the current ABR, 14 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 56% and 4% of all recommendations. A month ago, Strong Buy made up 54.17%, while Buy represented 4.17%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 14 | 13 | 13 | 13 | 13 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 10 | 10 | 10 | 10 | 9 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 1 |
ABR | 1.84 | 1.88 | 1.88 | 1.88 | 1.96 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/26/2024 | Argus Research Corp. | James N Kelleher | Not Available | Strong Buy |
7/25/2024 | Exane BNP Paribas | Jerome Ramel | Hold | Hold |
7/25/2024 | Cowen & Co. | Sreekrishnan Sankar | Hold | Hold |
7/25/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/25/2024 | Susquehanna Financial Group | Mehdi Hosseini | Hold | Hold |
7/25/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/25/2024 | Goldman Sachs | Toshiya Hari | Strong Buy | Strong Buy |
7/25/2024 | Evercore Partners | Mark Lipacis | Strong Buy | Strong Buy |
7/16/2024 | Cantor Fitzgerald & Co | Christopher J Muse | Hold | Hold |
7/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/15/2024 | UBS | Timothy Arcuri | Hold | Hold |
6/5/2024 | Not Identified | Not Identified | Strong Sell | Hold |
5/12/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
4/29/2024 | Berenberg Bank | Tammy Qiu | Strong Buy | Strong Buy |
4/26/2024 | KeyBanc Capital Markets | Steve Barger | Hold | Hold |
4/26/2024 | New Street Research | Pierre C Ferragu | Strong Buy | Strong Buy |
4/26/2024 | Raymond James | Srini Pajjuri | Moderate Buy | Moderate Buy |
4/22/2024 | Needham & Company | Charles Shi | Hold | Hold |
3/19/2024 | Wells Fargo Securities | Joe M Quatrochi | Strong Buy | Strong Buy |
1/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
11/22/2023 | Atlantic Equities | Timm Schulze-Melander | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.84 |
ABR (Last week) | 1.88 |
# of Recs in ABR | 25 |
Average Target Price | $870.91 |
LT Growth Rate | 17.30% |
Industry | Electronics - Miscellaneous Products |
Industry Rank by ABR | 155 of 253 |
Current Quarter EPS Est: | 7.02 |